Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125284542 | 12528454 | 2 | F | 2006 | 20160628 | 20160705 | 20160711 | EXP | US-DSJP-DSU-2016-110864 | DAIICHI | 56.28 | YR | F | Y | 129.00000 | KG | 20160711 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125284542 | 12528454 | 1 | PS | BENICAR HCT | HYDROCHLOROTHIAZIDEOLMESARTAN MEDOXOMIL | 1 | Oral | 40/12.5MG, UNK | U | 21532 | 1 | DF | FILM-COATED TABLET | QD | |||||
| 125284542 | 12528454 | 2 | SS | BENICAR HCT | HYDROCHLOROTHIAZIDEOLMESARTAN MEDOXOMIL | 1 | Oral | 20/12.5MG, QD | U | 21532 | 1 | DF | FILM-COATED TABLET | QD | |||||
| 125284542 | 12528454 | 3 | C | PROZAC | FLUOXETINE HYDROCHLORIDE | 1 | Oral | 20 MG, QD | 0 | 20 | MG | CAPSULE | QD | ||||||
| 125284542 | 12528454 | 4 | C | PROZAC | FLUOXETINE HYDROCHLORIDE | 1 | 40 MG, QD | 0 | 40 | MG | CAPSULE | QD | |||||||
| 125284542 | 12528454 | 5 | C | TRAZODONE | TRAZODONE HYDROCHLORIDE | 1 | UNK | 0 | |||||||||||
| 125284542 | 12528454 | 6 | C | LOPRESSOR | METOPROLOL TARTRATE | 1 | Oral | 50 MG 1/2 TABLET, BID | 0 | 25 | MG | TABLET | BID | ||||||
| 125284542 | 12528454 | 7 | C | LUNESTA | ESZOPICLONE | 1 | UNK | 0 | |||||||||||
| 125284542 | 12528454 | 8 | C | LASIX | FUROSEMIDE | 1 | UNK | 0 | |||||||||||
| 125284542 | 12528454 | 9 | C | KCL | POTASSIUM CHLORIDE | 1 | Oral | 10 MEQ, BID | 0 | 10 | MEQ | TABLET | BID | ||||||
| 125284542 | 12528454 | 10 | C | LYRICA | PREGABALIN | 1 | Oral | 75 MG, UNK | 0 | 75 | MG | CAPSULE | |||||||
| 125284542 | 12528454 | 11 | C | DONNATAL | ATROPINE SULFATEHYOSCYAMINE SULFATEPHENOBARBITALSCOPOLAMINE HYDROBROMIDE | 1 | UNK | 0 | |||||||||||
| 125284542 | 12528454 | 12 | C | PRILOSEC | OMEPRAZOLE MAGNESIUM | 1 | 30 MG, BID | 0 | 30 | MG | BID | ||||||||
| 125284542 | 12528454 | 13 | C | MOTRIN | IBUPROFEN | 1 | UNK | 0 | |||||||||||
| 125284542 | 12528454 | 14 | C | ASPRIN | ASPIRIN | 1 | Oral | 325 MG, QD | 0 | 325 | MG | TABLET | QD | ||||||
| 125284542 | 12528454 | 15 | C | LIPITOR | ATORVASTATIN CALCIUM | 1 | Oral | 40 MG, QD | 0 | 40 | MG | TABLET | QD | ||||||
| 125284542 | 12528454 | 16 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Oral | 1000 MG, BID | 0 | 1000 | MG | TABLET | BID | ||||||
| 125284542 | 12528454 | 17 | C | MOBIC | MELOXICAM | 1 | Oral | 15 MG, QD | 0 | 15 | MG | TABLET | QD | ||||||
| 125284542 | 12528454 | 18 | C | NEURONTIN | GABAPENTIN | 1 | Oral | 600 MG, BID | 0 | 600 | MG | TABLET | BID | ||||||
| 125284542 | 12528454 | 19 | C | PHENERGAN | PROMETHAZINE HYDROCHLORIDE | 1 | UNK | 0 | |||||||||||
| 125284542 | 12528454 | 20 | C | LORTAB | ACETAMINOPHENHYDROCODONE BITARTRATE | 1 | 7.5/500 MG, PRN | 0 | 1 | DF |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125284542 | 12528454 | 1 | Hypertension |
| 125284542 | 12528454 | 3 | Depression |
| 125284542 | 12528454 | 5 | Product used for unknown indication |
| 125284542 | 12528454 | 6 | Hypertension |
| 125284542 | 12528454 | 7 | Product used for unknown indication |
| 125284542 | 12528454 | 8 | Product used for unknown indication |
| 125284542 | 12528454 | 9 | Product used for unknown indication |
| 125284542 | 12528454 | 10 | Product used for unknown indication |
| 125284542 | 12528454 | 11 | Product used for unknown indication |
| 125284542 | 12528454 | 12 | Gastrooesophageal reflux disease |
| 125284542 | 12528454 | 13 | Product used for unknown indication |
| 125284542 | 12528454 | 14 | Product used for unknown indication |
| 125284542 | 12528454 | 15 | Hyperlipidaemia |
| 125284542 | 12528454 | 16 | Product used for unknown indication |
| 125284542 | 12528454 | 17 | Product used for unknown indication |
| 125284542 | 12528454 | 18 | Neuralgia |
| 125284542 | 12528454 | 19 | Product used for unknown indication |
| 125284542 | 12528454 | 20 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125284542 | 12528454 | OT |
| 125284542 | 12528454 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125284542 | 12528454 | Acute kidney injury | |
| 125284542 | 12528454 | Diverticulum intestinal | |
| 125284542 | 12528454 | Gastritis viral | |
| 125284542 | 12528454 | Gastroenteritis viral | |
| 125284542 | 12528454 | Haematochezia | |
| 125284542 | 12528454 | Hiatus hernia | |
| 125284542 | 12528454 | Infectious colitis | |
| 125284542 | 12528454 | Malabsorption | |
| 125284542 | 12528454 | Peptic ulcer |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125284542 | 12528454 | 1 | 20040518 | 2016 | 0 | |
| 125284542 | 12528454 | 2 | 20110301 | 0 |